Fulgent Genetics (FLGT) Current Assets (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Current Assets data on file, last reported at $479.0 million in Q1 2026.

• Quarterly Current Assets rose 14.94% year-over-year to $479.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $479.0 million (up 14.94% YoY) and the FY2025 annual result came in at $550.5 million, up 55.69% from the prior year.
• Current Assets retreated to $479.0 million in Q1 2026 per FLGT's latest filing, from $550.5 million in the prior quarter.
• The five-year high for Current Assets was $765.3 million in Q1 2022, with the low at $326.5 million in Q3 2024.
• Average Current Assets over 5 years is $516.5 million, with a median of $507.8 million recorded in 2023.
• Year-over-year, Current Assets tumbled 40.61% in 2024 and jumped 55.69% in 2025.
• Fulgent Genetics' Current Assets stood at $627.9 million in 2022, then dropped by 19.12% to $507.8 million in 2023, then plunged by 30.38% to $353.6 million in 2024, then surged by 55.69% to $550.5 million in 2025, then slipped by 12.98% to $479.0 million in 2026.
• Business Quant data shows FLGT's Current Assets at $479.0 million in Q1 2026, $550.5 million in Q4 2025, and $507.4 million in Q3 2025.